These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6721267)

  • 1. Theophylline clearance. Lack of effect of influenza vaccination and ascorbic acid.
    Bukowskyj M; Munt PW; Wigle R; Nakatsu K
    Am Rev Respir Dis; 1984 May; 129(5):672-5. PubMed ID: 6721267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of split virus influenza vaccination on theophylline pharmacokinetics.
    Grabowski N; May JJ; Pratt DS; Richtsmeier WJ; Bertino JS
    Am Rev Respir Dis; 1985 Jun; 131(6):934-8. PubMed ID: 2408526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccination and theophylline pharmacokinetics in patients with chronic obstructive lung disease.
    Stults BM; Hashisaki PA
    West J Med; 1983 Nov; 139(5):651-4. PubMed ID: 6659488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations].
    Ranke C; Schmidt G; Oellerich M; Sybrecht GW
    Prax Klin Pneumol; 1983 Mar; 37(3):99-108. PubMed ID: 6856564
    [No Abstract]   [Full Text] [Related]  

  • 5. Influenza vaccine may enhance theophylline toxicity. A case report and review of the literature.
    Hamdy RC; Micklewright M; Beecham VF; Moore SW
    J Tenn Med Assoc; 1995 Dec; 88(12):463-4. PubMed ID: 8531477
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of whole virus influenza vaccination on theophylline pharmacokinetics.
    Hannan SE; May JJ; Pratt DS; Richtsmeier WJ; Bertino JS
    Am Rev Respir Dis; 1988 Apr; 137(4):903-6. PubMed ID: 2451459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Individual theophylline doses following ambulatory determination of theophylline clearance].
    Harder S; Staib AH; Stauder J
    Prax Klin Pneumol; 1986 Aug; 40(8):334-8. PubMed ID: 3748986
    [No Abstract]   [Full Text] [Related]  

  • 8. Disposition and clinical pharmacokinetics of microcrystalline theophylline.
    Jonkman JH; Berg WC; Schoenmaker R; de Zeeuw RA; Greving JE; Orie NG
    Eur J Clin Pharmacol; 1980 May; 17(5):379-84. PubMed ID: 7418716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
    Wiesner B; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of influenza virus vaccine on hepatic drug metabolism.
    Meredith CG; Christian CD; Johnson RF; Troxell R; Davis GL; Schenker S
    Clin Pharmacol Ther; 1985 Apr; 37(4):396-401. PubMed ID: 3979001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased elimination of theophylline after influenza vaccination.
    Renton KW; Gray JD; Hall RI
    Can Med Assoc J; 1980 Aug; 123(4):288-90. PubMed ID: 7260771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine.
    Dal Negro R; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Turco P
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):221-6. PubMed ID: 6325354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of determining theophylline concentration in serum].
    Bonelli J; Dellinger C; Kraus M; Waginger H; Zanic P
    Wien Med Wochenschr; 1986 Dec; 136(23-24):641-6. PubMed ID: 3564492
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug monitoring: theophylline--comparison of 3 methods for determination].
    Kropp R; Göbel D
    Pneumologie; 1995 Feb; 49(2):60-4. PubMed ID: 7724504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of theophylline; variability and effect of arterial pH in chronic obstructive lung disease.
    Resar RK; Walson PD; Fritz WL; Perry DF; Barbee RA
    Chest; 1979 Jul; 76(1):11-6. PubMed ID: 36261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration.
    Vestal RE; Thummel KE; Musser B; Mercer GD
    Br J Clin Pharmacol; 1983 Apr; 15(4):411-8. PubMed ID: 6849776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampicin-isoniazid and delayed elimination of theophylline: a case report.
    Dal Negro R; Turco P; Trevisan F; De Conti F
    Int J Clin Pharmacol Res; 1988; 8(4):275-7. PubMed ID: 3182118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of the serum level of theophylline in a group of patients with chronic obstructive bronchopneumopathy].
    Marzo C; Gnasso P; Dericoloso A; Borrelli G; Vacca C; Cantone F
    Arch Monaldi; 1981; 36(1-2):71-5. PubMed ID: 7348162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.